A New Patent for CNS

Center for Neurologic Study
Dec 22, 2022
1 min read

The United States Patent and Trademark Office has notified CNS that they will be issued a patent on December 27th, 2022, for several unique pharmaceuticals which we believe will be useful for treating neurodegenerative diseases.

Recent Posts

See All

Dr. Smith to Speak at the International ALS MND Meeting, December 6-8, 2024

The title of his talk is " Seed-Amplification Assays: Windows into ALS and Kindred Diseases".

June 2024 - Qalsody (Tofersen) Approved For Use in Europe

Qualsody/Toferson conceived by CNS Director Dr. Smith and developed in collaboration with Don Cleveland (UCSD), Tim Miller (WashU), and...

April 16th, 2024 - "Chinese Translation and Validation of the Center for Neurologic Study Lability Scale" Published

The open access version of "Chinese Translation and Validation of the Center for Neurologic Study Lability Scale" has been published in...

Comentarios

< Back